Search

everythinglearnresearchcommunity

for

Search:↓

Skin issues in PCOS signal hormone problems, and combined treatments improve outcomes.

Hormonal imbalances are a key cause of missed menstrual periods in women.

High chromogranin A levels are linked to obesity and inflammation in polycystic ovary syndrome.

High prolactin levels might be linked to hair loss in autoimmune thyroid disease, but more research is needed.

Pregnancy can cause skin darkening, varicose veins, more sweating, hair growth, hair loss after birth, nail changes, and gum inflammation.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

Women with PCOS-related infertility can often conceive with treatments like clomiphene and metformin, but managing pregnancy complications is important.

A new non-invasive method can analyze skin mRNA to understand skin diseases better.

A new system helps better diagnose and treat female androgenization conditions like PCOS.

Serum steroid profiling, especially 11-deoxycortisol, helps distinguish between adrenocortical carcinoma and adenoma, considering sex and functional status.

Hormones are crucial for regulating body functions and imbalances can lead to health issues.

The conclusion is that analyzing RNA from skin oils is a promising way to understand skin diseases.

A thorough initial check-up is essential before sperm banking to ensure the best chance of preserving good quality sperm.

Korean patients with PCOS often have skin problems like acne and excess hair, with different symptoms based on their specific PCOS type.

The document concludes that management strategies for PCOS are important due to its common occurrence and associated health risks.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

Polycystic ovary syndrome is a complex condition that affects women's mental, reproductive, and metabolic health throughout their lives.

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

Spironolactone most effective for hirsutism, but has side effects.

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

Women with idiopathic hirsutism and PCOS have higher RBP4 levels, and PCOS is linked to greater insulin resistance; weight management may help both conditions.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

Normal-range ALT levels can indicate metabolic and hormonal imbalances in young women.

A group has developed therapies that show promise for treating cancer and various other conditions.

PCOS is a common disorder in women causing symptoms like irregular periods and weight gain, with management possible through lifestyle changes and medication.

Estrogens and progesterone are key in regulating melasma pigmentation.

Pubertal acne is linked to hormonal changes, affects quality of life, and is treated similarly to adult acne.

Glycemic control medications for Type 2 diabetes can affect skin conditions like psoriasis.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.